Andrew P Jackson Selected Research

Microcephaly

1/2021	Heterozygous lamin B1 and lamin B2 variants cause primary microcephaly and define a novel laminopathy.
11/2019	Clinical and Molecular Characterization of Familial Exudative Vitreoretinopathy Associated With Microcephaly.
1/2017	Corrigendum: Mutations in genes encoding condensins cause microcephaly through decatenation failure at mitosis.
10/2016	Mutations in genes encoding condensin complex proteins cause microcephaly through decatenation failure at mitosis.
1/2014	Extreme growth failure is a common presentation of ligase IV deficiency.
7/2009	BRIT1/MCPH1 links chromatin remodelling to DNA damage response.
10/2006	Microcephalin: a causal link between impaired damage response signalling and microcephaly.
8/2006	What primary microcephaly can tell us about brain growth.
7/2002	Identification of microcephalin, a protein implicated in determining the size of the human brain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew P Jackson Research Topics

Disease

9	Microcephaly 01/2021 - 07/2002
6	Infections 01/2021 - 08/2006
6	Genomic Instability 01/2018 - 05/2012
6	Dwarfism 04/2017 - 02/2011
5	Neoplasms (Cancer) 10/2018 - 01/2014
3	Inflammation (Inflammations) 10/2018 - 09/2008
3	Autoimmune Diseases (Autoimmune Disease) 01/2015 - 06/2013
2	African Trypanosomiasis (Nagana) 01/2021 - 02/2012
2	Bites and Stings (Sting) 12/2020 - 04/2016
2	Cone-Rod Dystrophies 01/2020 - 11/2019
2	Carcinogenesis 01/2020 - 10/2016
2	Brain Diseases (Brain Disorder) 01/2019 - 02/2015
2	Hypersensitivity (Allergy) 01/2018 - 01/2014
2	Type II Microcephalic Osteodysplastic Primordial Dwarfism 01/2017 - 11/2012
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2016 - 01/2015
2	Liver Diseases (Liver Disease) 09/2014 - 01/2012
2	Telangiectasis (Telangiectasia) 07/2014 - 10/2006
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Muscular Diseases (Myopathy) 01/2021
1	Laminopathies 01/2021
1	Parasitic Diseases (Parasitic Disease) 01/2021
1	Progeria (Hutchinson Gilford Syndrome) 01/2021
1	Atrophy 11/2019
1	Vivax Malaria 06/2019
1	Sepsis (Septicemia) 06/2019
1	sponastrime type Spondyloepimetaphyseal dysplasia 01/2019
1	Strudwick syndrome 01/2019
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2019
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2019
1	And Genital Anomalies Adrenal Hypoplasia Congenita Metaphyseal Dysplasia Intrauterine Growth Retardation 12/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Bloom Syndrome 01/2018
1	Chromothripsis 01/2017
1	Stroke (Strokes) 01/2017
1	Multiple Sclerosis 12/2016
1	Thrombotic Microangiopathies 12/2016
1	Malaria 11/2016
1	T-Cell Lymphoma (Lymphoma, T Cell) 10/2016
1	Type 2 Diabetes Mellitus (MODY) 09/2014
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2014
1	Virus Diseases (Viral Diseases) 08/2014
1	Hearing Loss (Hearing Impairment) 07/2014
1	Premature Aging 07/2014
1	Nijmegen Breakage Syndrome 01/2014
1	Inborn Genetic Diseases (Disease, Hereditary) 06/2013
1	Neuroinflammatory Diseases 05/2012
1	Persistent Infection 02/2012
1	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2011
1	Insulin Resistance 03/2011
1	Meier-Gorlin syndrome 02/2011
1	Leishmaniasis 09/2010
1	Ataxia (Dyssynergia) 10/2006

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2002
8	Ribonucleases (Ribonuclease)IBA 10/2018 - 08/2006
5	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 05/2012
5	EnzymesIBA 04/2016 - 09/2008
3	AntigensIBA 12/2020 - 02/2012
3	RibonucleotidesIBA 10/2018 - 05/2012
3	pericentrinIBA 01/2017 - 03/2011
3	condensin complexes (condensin)IBA 01/2017 - 10/2016
3	Nucleic AcidsIBA 04/2016 - 08/2014
3	Biomarkers (Surrogate Marker)IBA 09/2014 - 01/2012
2	VaccinesIBA 01/2021 - 06/2019
2	RNA (Ribonucleic Acid)IBA 06/2019 - 03/2014
2	Interferon Type IIBA 10/2018 - 12/2016
2	Ligases (Synthetase)IBA 01/2016 - 01/2014
2	Phosphotransferases (Kinase)IBA 12/2014 - 10/2006
2	Origin Recognition ComplexIBA 10/2011 - 02/2011
1	Lamin Type B (Lamin B)IBA 01/2021
1	Lamin Type A (Lamin A)IBA 01/2021
1	LaminsIBA 01/2021
1	InterferonsIBA 12/2020
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 12/2020
1	MitogensIBA 01/2020
1	Transaminases (Aminotransferases)IBA 01/2020
1	Retinaldehyde (Retinal)IBA 11/2019
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 06/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 06/2019
1	Peptides (Polypeptides)IBA 06/2019
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2019
1	Inosine TriphosphataseIBA 01/2019
1	CamptothecinIBA 01/2019
1	DNA Polymerase IIIBA 12/2018
1	Mitochondrial DNA (mtDNA)IBA 01/2018
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018
1	Exonucleases (3' 5' Exonuclease)IBA 01/2017
1	Biological ProductsIBA 11/2016
1	UbiquitinIBA 01/2016
1	Keratin-18 (Keratin 18)IBA 09/2014
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 07/2014
1	Pathogen-Associated Molecular Pattern MoleculesIBA 03/2014
1	Pattern Recognition ReceptorsIBA 03/2014
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 02/2012
1	Messenger RNA (mRNA)IBA 10/2011
1	Insulin (Novolin)FDA Link 03/2011
1	Immune Sera (Antisera)IBA 09/2010
1	A-Form DNA (A-DNA)IBA 10/2006

Therapy/Procedure

2	Therapeutics 01/2018 - 12/2016